貨號(hào)
產(chǎn)品規(guī)格
售價(jià)
備注
BN40582R-100ul
100ul
¥2360.00
交叉反應(yīng):Human,Mouse,Rat(predicted:Dog,Pig,Cow,Rabbit,Sheep,GuineaPig) 推薦應(yīng)用:WB,IHC-P,Flow-Cyt,ELISA
BN40582R-200ul
200ul
¥3490.00
交叉反應(yīng):Human,Mouse,Rat(predicted:Dog,Pig,Cow,Rabbit,Sheep,GuineaPig) 推薦應(yīng)用:WB,IHC-P,Flow-Cyt,ELISA
產(chǎn)品描述
英文名稱 | phospho-CDKN1B (Ser10) |
中文名稱 | 磷酸化P27抗體/周期素依賴激酶抑制劑 |
別 名 | p27 KIP 1 (phospho S10); p-p27 KIP 1 (phospho S10); p27Kip1(Phospho-Ser10); p-p27Kip1(Ser10); p-p27Kip1(S10); CDN1B_HUMAN; AA408329; AI843786; Cdki1b; CDKN 1B; CDKN 4; CDKN1B; CDKN1B; CDKN4; CDKN4; Cyclin Dependent Kinase Inhibitor 1B; Cyclin Dependent Kinase Inhibitor 1B; Cyclin dependent kinase inhibitor p27; Cyclin dependent kinase inhibitor p27; Cyclin-dependent kinase inhibitor 1B (p27, Kip1); Cyclin-dependent kinase inhibitor 1B; Cyclin-dependent kinase inhibitor p27; Cyclin-dependent kinase inhibitor p27 Kip1; KIP 1; KIP1; MEN1B; MEN4; OTTHUMP00000195098; OTTHUMP00000195099; p27; p27 Kip1; P27-like cyclin-dependent kinase inhibitor; P27KIP1. |
研究領(lǐng)域 | 免疫學(xué) 細(xì)胞周期蛋白 激酶和磷酸酶 |
抗體來(lái)源 | Rabbit |
克隆類(lèi)型 | Polyclonal |
交叉反應(yīng) | Human, Mouse, Rat, (predicted: Dog, Pig, Cow, Rabbit, Sheep, Guinea Pig, ) |
產(chǎn)品應(yīng)用 | WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:100-500 Flow-Cyt=1μg/Test (石蠟切片需做抗原修復(fù)) not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
分 子 量 | 22kDa |
細(xì)胞定位 | 細(xì)胞核 細(xì)胞漿 |
性 狀 | Liquid |
濃 度 | 1mg/ml |
免 疫 原 | KLH conjugated synthesised phosphopeptide derived from human CDKN1B around the phosphorylation site of Ser10:NG(p-S)PS |
亞 型 | IgG |
純化方法 | affinity purified by Protein A |
儲(chǔ) 存 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
保存條件 | Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. |
PubMed | PubMed |
產(chǎn)品介紹 | This gene encodes a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state. [provided by RefSeq, Jul 2008] Function: Important regulator of cell cycle progression. Involved in G1 arrest. Potent inhibitor of cyclin E- and cyclin A-CDK2 complexes. Forms a complex with cyclin type D-CDK4 complexes and is involved in the assembly, stability, and modulation of CCND1-CDK4 complex activation. Acts either as an inhibitor or an activator of cyclin type D-CDK4 complexes depending on its phosphorylation state and/or stoichometry. Subunit: Forms a ternary compex with CCNE1/CDK2/CDKN1B. Subcellular Location: Nucleus. Cytoplasm. Endosome. Note=Nuclear and cytoplasmic in quiescent cells. AKT-or RSK-mediated phosphorylation on Thr-198, binds 14-3-3, translocates to the cytoplasm and promotes cell cycle progression. Mitogen-activated UHMK1 phosphorylation on Ser-10 also results in translocation to the cytoplasm and cell cycle progression. Phosphorylation on Ser-10 facilitates nuclear export. Translocates to the nucleus on phosphorylation of Tyr-88 and Tyr-89. Colocalizes at the endosome with SNX6; this leads to lysosomal degradation. Tissue Specificity: Expressed in all tissues tested. Highest levels in skeletal muscle, lowest in liver and kidney. Post-translational modifications: Phosphorylated; phosphorylation occurs on serine, threonine and tyrosine residues. Phosphorylation on Ser-10 is the major site of phosphorylation in resting cells, takes place at the G(0)-G(1) phase and leads to protein stability. Phosphorylation on other sites is greatly enhanced by mitogens, growth factors, cMYC and in certain cancer cell lines. The phosphorylated form found in the cytoplasm is inactivate. Phosphorylation on Thr-198 is required for interaction with 14-3-3 proteins. Phosphorylation on Thr-187, by CDK2 leads to protein ubiquitination and proteasomal degradation. Tyrosine phosphorylation promotes this process. Phosphorylation by PKB/AKT1 can be suppressed by LY294002, an inhibitor of the catalytic subunit of PI3K. Phosphorylation on Tyr-88 and Tyr-89 has no effect on binding CDK2, but is required for binding CDK4. Dephosphorylated on tyrosine residues by G-CSF. Ubiquitinated; in the cytoplasm by the KPC complex (composed of RNF123/KPC1 and UBAC1/KPC2) and, in the nucleus, by SCF(SKP2). The latter requires prior phosphorylation on Thr-187. Ubiquitinated; by a TRIM21-containing SCF(SKP2)-like complex; leads to its degradation. DISEASE: Defects in CDKN1B are the cause of multiple endocrine neoplasia type 4 (MEN4) [MIM:610755]. Multiple endocrine neoplasia (MEN) syndromes are inherited cancer syndromes of the thyroid. MEN4 is a MEN-like syndrome with a phenotypic overlap of both MEN1 and MEN2. Similarity: Belongs to the CDI family. SWISS: P46527 Gene ID: 1027 Database links: Entrez Gene: 1027 Human Entrez Gene: 12576 Mouse Omim: 600778 Human SwissProt: P46527 Human SwissProt: P46414 Mouse Unigene: 238990 Human Unigene: 2958 Mouse Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 国产午夜精品理论片A级探花 | ww黄网站在线观看免费 | 精品久久久久久无码人妻热桃花 | 国产极品JK白丝喷白浆羞视频播放 | 中文字幕AV在线观看 | 高潮到失禁变态另类视频 | 海角亂倫精品一区二区 | 国产Aα麻豆成人对白视频 人妻多毛丰满熟妇av无码 | 精品无码秘 人妻一区二蜜桃 | 国内精品久久久久久久影视麻生 | 久久夜色撩人国产综合AV | 国产suv精品一区二区 | 国产一级A片久久久免费看快餐 | 亚洲国产无码精品 | 99久久精品人妻无码一区二区蜜桃 | 成人在线视频免费 | 久久国产成人精品Av | 久久99国产精品1区二区 | 日本无码少妇成人久久丫 | 久久Av一区二区三区杨思敏 | 在线视频中文字幕 | 激情一区二区三区 | 国产全是老熟女太爽了 | 午夜成人电影免费在线 | 久久久久久久久久久网站 | 亚洲精品久久久久久久久久久久久 | 人人做人人澡人人爽欧美 | 亚洲免费视频在线观看免费 | 99久久久无码国产精品68 | 91精品人妻少妇无码影院 | 国产传媒18精品免费观看 | 永久免费无码中文字幕 | 国产人妻无码一区二区三区 | 久久久久一区二区三区 | 极品媚黑91黑人在线播放 | 亚洲精品无码成人A片在线沈先生 | 免费一看一级毛片少妇丰满 | 成年免费视频黄网站在线观看 | 女生双腿白浆高潮的视频 | 国产精品 国产17 |